N03AX11 - Topiramate |
Probably porphyrinogenic |
PRP |
Rationale
Substrate for 3A4. Ligand to PXR and light to moderately strong inducer of CYP 3A4.
Chemical description
(To be edited, initial data ST OCT 04) Tabl; 200-1000 mg/d. Sulfamate substituted monosaccharide used for additional treatment in patients with partial or generalized epileptic attacks. Metabolized by CYP 3A. Nallani et al. Topiramate. An antiepileptic agent that activates pregane X receptror and induces cytochrome P450 3A4 enzyme. Drug metab Rev Abstr 8th Europ Meeeting, Dijon….2003: Vol 35; Abs 159, p 80.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
© NAPOS 2024